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Introduction
Capsule endoscopy (CE) represents a significant advance
in the investigation of small bowel disease. The diagnostic
power of CE continues to improve while its scope of
use has expanded to include evaluation of obscure
gastrointestinal bleeding (OGIB), Crohn disease, in-
testinal tumors, polyposis, and other small bowel 
diseases1–5.
Among various small bowel diagnoses, angiodysplas-
tic lesions of the small bowel were more accurately
identified compared with other pathologies6. Angiodys-
plastic lesions are the most frequent cause of OGIB,
accounting for about 30–40% of lesions. Unfortunately,
there is a lack of comprehensive epidemiologic studies
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for OGIB in the elderly7–10. This study reports the risk
factors of OGIB with CE in the elderly.
Materials and Methods
A retrospective study was performed on 152 patients
who underwent CE between March 2004 and November
2008. Clinical and other data were collected and evalu-
ated retrospectively. Patients without OGIB and patients
whose examination did not reach the cecum capsule
were excluded. The patient flow chart is summarized in
Table 1. All patients had undergone at least one upper
endoscopy and colonoscopy prior to performance of
CE. All the patients signed the informed consent.
To analyze possible risk factors for angiodysplasia
in the elderly, we systematically assessed several poten-
tial risk factors: (1) chronic liver disease; (2) past med-
ical history of heart disease; (3) diabetes mellitus; (4)
pulmonary disease; and (5) chronic renal disease.
CE procedure
After an overnight fast of 12 hours, all patients swal-
lowed the CE. Patients were allowed to drink 2 hours
after ingesting the capsule and to eat a light meal 4 hours
later. Patients were free to leave the endoscopy depart-
ment, with instructions to return about 7–8 hours after
ingestion to have the recorder disconnected. The re-
corded information was downloaded into the computer,
and images from the stomach and the small bowel were
analyzed using the RAPID 3 software (Given Imaging Ltd.,
Yoqneam, Israel). The intestinal transit time was calcu-
lated from the first view of duodenum until the cecum
was reached. The study was regarded as “positive” when
at least one highly relevant lesion was found (P2), “neg-
ative” when the abnormality found could not explain
blood loss (P1), or when no abnormality (P0) was seen.
Statistical analysis
Comparisons between categorical measures were car-
ried out using χ2 test using the phi correlation for an
index between nominal variables. To identify possible
factors associated with angiodysplastic lesion, all possible
factors were examined by a binary logistic regression
analysis. Odds ratio and corresponding 95% confidence
intervals were generated for all variables. A p value
< 0.05 was regarded as statistically significant. SPSS
13.0 (SPSS Inc., Chicago, IL, USA) for Windows was used in
all statistical analyses.
Results
In total, 152 CE studies were reviewed. Of these, 121
studies were used in the statistical analysis after exclu-
sions were made, as shown in Table 1. The mean age of
the patients was 57.9 years (range, 13–89 years; 41.3%
women). Using CE, the most commonly detected bleed-
ing sources or clues in the small bowel included angio-
dysplasias (red flat mucosal lesions with visible
borders), active bleeding (fresh blood localization with-
out definite lesion identified), ulcers (an interruption
of the mucosa with visible depth) and tumors (Figure).
Angiodysplastic lesions found in small intestine are
listed by age distribution in Table 2. When stratified
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Table 1. Patient flow chart
Patient pool (152 patients considered for the study)
Excluded: 12 patients without obscure gastrointestinal
bleeding found clinically
Excluded: 10 patients with short duration of capsule batteries
Excluded: 9 patients with capsule not reaching the cecum
Table 2. Angiodysplastic and non-angiodysplastic lesions
in small intestine by age distribution
Age ≥ 65 Age < 65 
All
years years
Lesion, n (%)
Angiodysplastic 25 (52) 18 (25) 43 (36)
Non-angiodysplastic 23 (48) 55 (75) 78 (64)
Total 48 (100) 73 (100) 121 (100)
Angio-
dysplasia
0
5
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Bleeding Ulcers Tumor
Age ≥ 65 yr
Age < 65 yr
Figure. Positive findings for 121 patients undergoing capsule
endoscopy.
according to age, the occurrence of angiodysplastic
lesions was 52% in the older population and 25% in
the younger population (p < 0.01).
Results of binary logistic regression analysis for all
cases investigated revealed possible risk factors for
angiodysplastic lesions (Table 3). The main factor asso-
ciated with angiodysplastic lesions was increased age
(≥ 65 years). Because aortic stenosis is a known risk
factor for angiodysplasia, we analyzed whether a past
medical history of heart disease was a risk factor for
angiodysplasia. These patients did not have an in-
creased risk for angiodysplasia (odds ratio, 0.83; 95%
confidence interval, 0.20–3.48; p = 0.80), and neither
did patients with chronic renal disease (odds ratio,
2.47; 95% confidence interval, 0.70–8.71; p = 0.16).
Discussion
The number of people older than 65 years constitutes a
substantial and growing proportion of the population
in Taiwan11. Worldwide, the number of persons older
than 65 years will approach 750 million by 205012. Old
age, primarily because of associated comorbidity, may
dramatically influence the prognosis of some gastroin-
testinal diseases, such as gastrointestinal bleeding13.
Unfortunately, because of age-related changes in pain
perception, the clinical manifestations of these disorders
may be atypical and variable, resulting in a delayed
diagnosis.
OGIB could be subclassified as obscure-overt bleed-
ing, defined as recurrent passage of visible blood, and
obscure-occult bleeding, defined as recurrent iron defi-
ciency anemia and/or recurrent positive fecal occult
blood test results14,15. The common causes of OGIB are
vascular lesions, ulceration, small bowel tumors, and
jejunal diverticulosis16,17. The diagnostic yield of CE for
the suspected bleeding source in patients with OGIB has
been reported to range from 38% to 93%18. The small
bowel is the most likely source of bleeding in patients
with continuing blood loss and negative upper and
lower gastrointestinal endoscopies. This tumor loca-
tion is particularly true in patients < 50 years, in whom
small bowel mass lesions are most frequently diag-
nosed19. Alternative methods for evaluating the small
bowel include balloon-assisted enteroscopy, angiog-
raphy, radionuclide imaging, enteroclysis, computed
tomography, and magnetic resonance enterography.
Their diagnostic yield depends on several factors, such
as availability, clinical condition, and the experience
of the interpreter. In elderly patients, it may be diffi-
cult to obtain many of these studies in a noninvasive
manner.
Angiodysplastic lesions are the most frequent cause
of OGIB. Individuals with large and numerous angiodys-
plastic lesions had higher transfusion requirements,
lower hemoglobin levels, higher rebleeding rates, and
a higher proportion of therapeutic procedures per-
formed after CE20. Although an endoscopic classifica-
tion for vascular lesions of the small bowel has been
established18, their cause is unknown and the result of
a degenerative process associated with aging is proba-
ble. Junquera et al.21 proposed that incremental vas-
cular endothelial growth factor expression appears to
play a pathogenic role in the development of colonic
angiodysplasia. Angiodysplasia in the upper gastroin-
testinal tract has been claimed to occur with higher
frequency in patients with renal failure, diabetes, aortic
stenosis, cirrhosis, and pulmonary disease8. Previous
reports on the prevalence of angiodysplasia in renal
failure patients are conflicting. However, those studies
used data obtained by conventional upper gastroin-
testinal endoscopy22,23. Our report demonstrates that
angiodysplastic lesions could be responsible for OGIB
in elderly patients even when not associated with
other medical risk factors.
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Table 3. Binary logistic regression analysis for factors associated with angiodysplastic lesion
Variable OR 95% CI p
Age ≥ 65 years 2.76 1.20–6.35 0.02
Chronic liver disease 1.07 0.31–3.73 0.91
Past medical history of heart disease 0.83 0.20–3.48 0.80
Diabetes mellitus 0.64 0.15–2.78 0.55
Pulmonary disease 2.38 0.20–28.06 0.49
Chronic renal disease 2.47 0.70–8.71 0.16
OR = odds ratio; CI = confidence interval.
Our study has one major limitation due to the rel-
atively small number of patients included and the use
of a retrospective database, which, even though, was
correctly built. Thus, further large prospective studies
are needed to confirm our results. Moreover, given the
inherently subjective nature of endoscopic interpreta-
tions, some degree of interobserver variability may have
occurred in the identification of angiodysplastic lesions.
CE is a new technology developed to investigate
gastrointestinal bleeding of the small intestine. It has
been shown to be superior to current modalities such as
small bowel barium radiology and push enteroscopy24.
CE as a novel endoscopic procedure for small bowel
diagnosis has prompted a reclassification of the termi-
nology of gastrointestinal tract25,26.
The main disadvantages of CE include capsule reten-
tion27,28, false-negative results, and the lack of means
for tissue proof or therapeutic intervention. Before
using CE in patients at higher risk for capsule retention
(e.g., those with Crohn disease and small bowel obstruc-
tion), patients should be made fully aware of the poten-
tial need for surgery. If patients are unwilling or unfit to
have surgery, CE should not be performed. Retention
of the capsule may establish a definitive diagnosis and
indicate the presence of a lesion requiring surgery with-
out precipitating acute obstruction. This was the case
in one of our subjects; capsule retention was noted
owing to small bowel diverticulosis, but gastrointesti-
nal stromal tumor was found during push enteroscopy
and was confirmed by surgery.
A recent meta-analysis of 24 studies included 530
patients, 310 of whom had OGIB29. The patients had
undergone an average of 6.77 diagnostic procedures
without findings. Of 727 pathologies in bleeding stud-
ies, the 317 (43.6%) that were identified by CE were
vascular lesions. Our results (angiodysplastic lesions in
elderly versus in total patients, 25/48 [52%] vs. 43/121
[36%]) were consistent with the results of previous
studies29.
In conclusion, a diagnostic CE will direct appropri-
ate medical, endoscopic or surgical interventions. The
use of CE can be considered another useful tool for the
physician in the evaluation of OGIB among the elderly.
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